HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 16533Erstellt: 26. Oktober 2026
9-Fluor-11β,17,21-trihydroxy-16β-methylpregna-1,4-dien-3,20-dion-17-valerat
BETAMETHASONE VALERATE · VALISONE · Betaderm · BETNOVATE · BETHAMETASONE VALERATE · Luxiq · Betoid · Valison
https://huagongshe.com/de/chemical/16533
Identifikatoren & physikalische Daten
| CAS No. | 2152-44-5 |
|---|
| Summenformel | C27H37FO6 |
|---|
| Durchschnittliche Molmasse | 476,6 g/mol |
|---|
| Monoisotopische Masse | 476,25741712 g/mol |
|---|
| SMILES | CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C |
|---|
| InChIKey | SNHRLVCMMWUAJD-SUYDQAKGSA-N |
|---|
| PubChem CID | 16533 |
|---|
| ChEMBL | CHEMBL1497 |
|---|
| ChEBI | CHEBI:31277 |
|---|
| EC No. | 218-439-3 |
|---|
| DTXSID | DTXSID7022673 |
|---|
| Lokaler Name | 9-Fluor-11β,17,21-trihydroxy-16β-methylpregna-1,4-dien-3,20-dion-17-valerat |
|---|
Chemische & physikalische Eigenschaften
| XLogP | 3,6 |
|---|
| Polarare Oberfläche (TPSA) | 101 |
|---|
| H-Brücken-Donoren | 2 |
|---|
| H-Brücken-Akzeptoren | 7 |
|---|
| Frei drehbare Bindungen | 7 |
|---|
| Schwere Atome | 34 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 957 |
|---|
| Arzneimittel | Pharmaceuticals -> Dermatologicals -> Corticosteroids, dermatological preparations |
|---|
| Human Drugs | FDA approved drugs -> Active ingredient |
|---|
| Animal Drugs | Active Ingredients (Betamethasone Valerate) -> FDA Greenbook |
|---|
| Endocrine Disruptors | Potential endocrine disrupting compound |
|---|
| Collision Cross Section | 215.5 Ų [M-H]- [CCS Type: DTBuffer gas: N2Ionization: ESI-Dataset: TOXCASTSource Identifier: DTXSID7022673]214 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards] |
|---|
| Schmelzpunkt | 183-184° |
|---|
| Siedepunkt | 598.9±50.0 °C(Predicted) |
|---|
| Dichte | 1.1174 (estimate) |
|---|
| Lagerbedingungen | 2-8°C |
|---|
| Löslichkeit | Practically insoluble in water, freely soluble in acetone and in methylene chloride, soluble in ethanol (96 per cent). |
|---|
| pKa (Säurekonstante) | 12.90±0.70(Predicted) |
|---|
| Aggregatzustand | Solid |
|---|
| Farbe | White |
|---|
| Merck | 13,1183 |
|---|
| BRN | 4240001 |
|---|
| InChIKey | SNHRLVCMMWUAJD-SUYDQAKGSA-N |
|---|
| SMILES | [C@]12(C)C[C@@H]([C@]3(F)[C@@]4(C)C=CC(=O)C=C4CC[C@@]3([H])[C@]1([H])C[C@H](C)[C@@]2(C(=O)CO)OC(=O)CCCC)O |&1:0,3,4,6,16,18,21,23,r| |
|---|
| CAS Datenbank | 2152-44-5(CAS DataBase Reference) |
|---|
| EPA chemische Informationen | .beta.-Methasone 17-valerate (2152-44-5) |
|---|
Sicherheit & Vorschriften
| GHS-Einstufung | DangerH330 (35.6%): Fatal if inhaled [Danger Acute toxicity, inhalation]P203, P260, P264, P270, P271, P273, P280, P284, P304+P340, P316, P318, P319, P320, P391, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 146 reports by companies from 21 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|
| Regulatorische Informationen | Betamethasone valerate: Does not have an individual approval but may be used under an appropriate group standard |
|---|
| Weitere Sicherheitsinformationen | IMAP assessments - Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11.beta.,16.beta.)-: Environment tier I assessment |
|---|
| Hazard Classes and Categories | Acute Tox. 2 (35.6%) |
|---|
| Wassergefährdungsklasse (WGK) | WGK 2 |
|---|
| Zollcode | 2937229000 |
|---|
| RTECS-Nr. | TU3835000 |
|---|
| R-Sätze (R) | 48 |
|---|
| Toxizität | mouse,LD50,intraperitoneal,632mg/kg (632mg/kg),Shikoku Igaku Zasshi. Shikoku Medical Journal. Vol. 29, Pg. 153, 1973. |
|---|
| Gefahrensymbole | Xn |
|---|
| Sicherheitshinweise (S) | 22-24/25 |
|---|
| Lagerklasse | 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects |
|---|
| Gefahrenklasse | Repr. 1BSTOT RE 2 |
|---|